Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sigyn Therapeutics, Inc. (SIGY) Income from Continuing Operations (2017 - 2025)

Updated

Sigyn Therapeutics (SIGY) reported Income from Continuing Operations of -$578,503 for Q3 2025, compared with -$1.2 million a year earlier.

Analysis

Sigyn Therapeutics, Inc. (SIGY) Income from Continuing Operations (2017 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Sigyn Therapeutics' Income from Continuing Operations came in at -$3.22 million; for FY2024, it was -$3.34 million.

  • By year, Income from Continuing Operations came in at -$4.15 million in FY2023, -$2.93 million in FY2022, -$3 million in FY2021 and -$1.26 million in FY2020.
  • Five-year quarterly Income from Continuing Operations spans a low of -$1.45 million in Q2 2025 and a high of -$452,022 in Q4 2020.
  • Per Business Quant data, the three quarters before Q3 2025 came in at -$1.45 million (Q2 2025), -$668,564 (Q1 2025) and -$522,818 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -578,503.00
Jun 30, 2025 -1.45 Mn
Mar 31, 2025 -668,564.00
Dec 31, 2024 -522,818.00
Sep 30, 2024 -1.20 Mn
Jun 30, 2024 -862,383.00
Mar 31, 2024 -758,088.00
Dec 31, 2023 -1.18 Mn
Sep 30, 2023 -905,726.00
Jun 30, 2023 -723,124.00
Mar 31, 2023 -1.34 Mn
Dec 31, 2022 -858,937.00
Sep 30, 2022 -726,509.00
Jun 30, 2022 -666,325.00
Mar 31, 2022 -678,046.00
Dec 31, 2021 -1.23 Mn
Sep 30, 2021 -665,904.00
Jun 30, 2021 -649,861.00
Mar 31, 2021 -461,682.00
Dec 31, 2020 -452,022.00
API Access

Sigyn Therapeutics, Inc. Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SIGY&period=max&api_key=YOUR_API_KEY